CNMD
CONMED·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 3
Ample Liquidity
High Gross Profit Margin
Gap Down
Significant Net Income Decline
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About CNMD
Conmed Corporation
A medical technology company that provides surgical devices and equipment for minimally invasive procedures
Healthcare Equipment and Supplies
--
02/10/2020
New York Stock Exchange
3,900
12-31
Common stock
11311 Concept Boulevard, Largo, Florida 33773
--
CONMED Corporation was incorporated in 1970 under the laws of the State of New York and became a Delaware corporation in May 2020. CONMED is a medical technology company focused on surgical instruments and devices for minimally invasive surgery and monitoring. The company's products are mainly used by surgeons and attending physicians in various specialties including orthopedics, general surgery, obstetrics and gynecology, neurosurgery, and gastroenterology. The company's main goal is to improve the quality of surgical outcomes and patient care through the development of Innovative Medical devices, improvements to existing products and the development of new technologies, and to reduce risk, trauma, cost and time of surgery. The Company believes that by meeting these objectives, it can improve its forecasting ability, adapt to customer needs and market opportunities, and generate substantial return on investment for shareholders.
Earnings Call
Q1/2025
Estimate EPS0.81
Actual EPS0.95
Estimate Revenue313.38M
Actual Revenue321.30M
CONMED's Q1 2025: Unpacking Contradictions in Strategy, Pricing, and Market Growth
May 07,2025 07:24
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS1.12
Actual EPS1.15
Estimate Revenue338.42M
Actual Revenue342.34M
CONMED's 2025 Q2 Earnings Call: Unpacking Contradictions in Market Share, Supply Chains, and Innovation
Jul 30,2025 10:55
Earnings Decrypt
Earnings Decrypt
Q3/2025
Estimate EPS1.05
Actual EPS1.08
Estimate Revenue334.76M
Actual Revenue337.90M
CONMED's Q3 2025: Contradictions Emerge on AirSeal Utilization, Capital Environment, Tariffs, and Supply Chain
Nov 05,2025 10:25
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
CNMD has released its 2025 Q3 earnings. EPS was reported at 1.08, versus the expected 1.05, beating expectations. The chart below visualizes how CNMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
CNMD has released its 2025 Q3 earnings report, with revenue of 337.93M, reflecting a YoY change of 6.70%, and net profit of 2.86M, showing a YoY change of -94.16%. The Sankey diagram below clearly presents CNMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
